tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

ARWR Stock Latest News

Arrowhead files automatic mixed securities shelf
The FlyArrowhead files automatic mixed securities shelf
3d ago
ARWR
Arrowhead price target raised to $80 from $52 at RBC Capital
PremiumThe Fly
Arrowhead price target raised to $80 from $52 at RBC Capital
3d ago
ARWR
Analyst Recommends Buy Rating for Arrowhead Pharmaceuticals Due to Promising Obesity Treatment Potential
PremiumRatings
Analyst Recommends Buy Rating for Arrowhead Pharmaceuticals Due to Promising Obesity Treatment Potential
5d ago
ARWR
Arrowhead price target raised to $81 from $62 at BofA
PremiumThe Fly
Arrowhead price target raised to $81 from $62 at BofA
5d ago
ARWR
Cautious Optimism for Arrowhead Pharmaceuticals Amid Competitor’s Positive Obesity Treatment Data
PremiumRatings
Cautious Optimism for Arrowhead Pharmaceuticals Amid Competitor’s Positive Obesity Treatment Data
6d ago
ARWR
Morgan Stanley sees positive readthrough to Arrowhead pipeline from Wave data
PremiumThe FlyMorgan Stanley sees positive readthrough to Arrowhead pipeline from Wave data
6d ago
WVE
ARWR
Arrowhead doses first subjects in ARO-MAPT trial
Premium
The Fly
Arrowhead doses first subjects in ARO-MAPT trial
6d ago
ARWR
Arrowhead rises 9.7%
Premium
The Fly
Arrowhead rises 9.7%
11d ago
ARWR
Arrowhead receives Breakthrough Therapy designation for plozasiran
PremiumThe Fly
Arrowhead receives Breakthrough Therapy designation for plozasiran
12d ago
ARWR
Arrowhead price target raised to $85 from $80 at H.C. Wainwright
PremiumThe Fly
Arrowhead price target raised to $85 from $80 at H.C. Wainwright
12d ago
ARWR
Arrowhead price target raised to $62 from $42 at BofA
PremiumThe Fly
Arrowhead price target raised to $62 from $42 at BofA
13d ago
ARWR
Arrowhead falls -8.3%
PremiumThe Fly
Arrowhead falls -8.3%
16d ago
ARWR
Arrowhead Pharmaceuticals at Risk: Potential Generic Competition Threatens REDEMPLO’s Market Exclusivity
PremiumCompany AnnouncementsArrowhead Pharmaceuticals at Risk: Potential Generic Competition Threatens REDEMPLO’s Market Exclusivity
17d ago
ARWR
Arrowhead Pharmaceuticals’ Earnings Call Highlights FDA Approval and Strong Financials
Premium
Company Announcements
Arrowhead Pharmaceuticals’ Earnings Call Highlights FDA Approval and Strong Financials
18d ago
ARWR
Arrowhead rises 23.4%
Premium
The Fly
Arrowhead rises 23.4%
18d ago
ARWR
Arrowhead rises 9.0%
PremiumThe Fly
Arrowhead rises 9.0%
18d ago
ARWR
Arrowhead price target raised to $48 from $45 at Morgan Stanley
PremiumThe Fly
Arrowhead price target raised to $48 from $45 at Morgan Stanley
18d ago
ARWR
Arrowhead Pharmaceuticals: Promising Growth with Redemplo Launch and Strategic Developments in Obesity Treatments
PremiumRatings
Arrowhead Pharmaceuticals: Promising Growth with Redemplo Launch and Strategic Developments in Obesity Treatments
18d ago
ARWR
Arrowhead Pharmaceuticals: Hold Rating Amid Redemplo Launch and Financial Stability
PremiumRatings
Arrowhead Pharmaceuticals: Hold Rating Amid Redemplo Launch and Financial Stability
18d ago
ARWR
Arrowhead Pharmaceuticals Reports Transformative Year-End Results
PremiumCompany AnnouncementsArrowhead Pharmaceuticals Reports Transformative Year-End Results
18d ago
ARWR
Arrowhead reports FY25 EPS (1c), consensus (3c)
Premium
The Fly
Arrowhead reports FY25 EPS (1c), consensus (3c)
19d ago
ARWR
Arrowhead options imply 11.3% move in share price post-earnings
Premium
The Fly
Arrowhead options imply 11.3% move in share price post-earnings
19d ago
ARWR

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >